Author:
Edition: 2012
Publisher: Springer
Binding: Hardcover
ISBN: 1461412153
Signaling Pathways in Cancer Pathogenesis and Therapy
In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. Medical books Signaling Pathways in Cancer Pathogenesis and Therapy. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies Medical books Signaling Pathways In Cancer Pathogenesis And Therapy By Hardcover Book (eng. Store Search search Title, ISBN and Author Signaling Pathways in Cancer Pathogenesis and Therapy Estimated delivery 3-12 business days Format Hardcover Condition Brand New This book describes research suggesting that abnormal activation of signaling pathways is a critical event in cancer pathogenesis, and describes the emerging ability to design small molecules, protein therapeutics, and other forms of targeted cancer therapies. Publisher Description In recent years, increasing evidence has sug
Download link for Signaling Pathways In Cancer Pathogenesis And Therapy - Frank, David A. (edt
Store Search search Title, ISBN and Author Signaling Pathways in Cancer Pathogenesis and Therapy Estimated delivery 3-12 business days Format Hardcover Condition Brand New This book describes research suggesting that abnormal activation of signaling pathways is a critical event in cancer pathogenesis, and describes the emerging ability to design small molecules, protein therapeutics, and other forms of targeted cancer therapies. Publisher Description In recent years, increasing evidence has sug
Signaling Pathways in Cancer Pathogenesis and Therapy SPVMD 9781461412151 09781461412151
In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein
"In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protei
Medical Book Signaling Pathways in Cancer Pathogenesis and Therapy
In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies.
